Egg yolk lecithin - Phosphatidylcholine (PC) > 90%, high purity , CAS No.93685-90-6

  • Phosphatidylcholine (PC) > 90%
Item Number
L305002
Grouped product items
SKUSizeAvailabilityPrice Qty
L305002-1g
1g
3
$109.90
L305002-5g
5g
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$379.90
L305002-25g
25g
2
$1,299.90

Discover Egg yolk lecithin by Aladdin Scientific in Phosphatidylcholine (PC) > 90% for only $109.90. Available - in Ligands at Aladdin Scientific. Tags: .

Basic Description

SynonymsLecithin from Egg;Lecithin from egg yolk pure;Egg PC;L-α-Phosphatidylcholine
Specifications & PurityPhosphatidylcholine (PC) > 90%
Storage TempProtected from light,Store at -20°C
Shipped InIce chest + Ice pads
Product Description

product description:

Phosphatidylcholine (PC) is a critical component of the mucosal layer of the colon and is the most common phospholipid in mammalian membranes. It is a strong bilayer-forming lipid.

Total Egg Extract is prepared by extracting powdered egg yolk with methanol. The methanol extract is partitioned with chloroform and deionized water, and the chloroform phase containing the organic soluble lipids is concentrated.

AI Insight

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

19 results found

Lot NumberCertificate TypeDateItem
K2323481Certificate of AnalysisNov 09, 2023 L305002
K2323480Certificate of AnalysisNov 09, 2023 L305002
K2323479Certificate of AnalysisNov 09, 2023 L305002
J2410602Certificate of AnalysisNov 09, 2023 L305002
H2309338Certificate of AnalysisJul 27, 2023 L305002
H2323333Certificate of AnalysisJul 27, 2023 L305002
H2309339Certificate of AnalysisJul 27, 2023 L305002
H2309336Certificate of AnalysisJul 27, 2023 L305002
H2309335Certificate of AnalysisJul 27, 2023 L305002
G2325055Certificate of AnalysisNov 03, 2022 L305002
K22171055Certificate of AnalysisNov 03, 2022 L305002
K22171056Certificate of AnalysisNov 03, 2022 L305002
K22171057Certificate of AnalysisNov 03, 2022 L305002
G2230365Certificate of AnalysisJul 15, 2022 L305002
G2230364Certificate of AnalysisJul 15, 2022 L305002
G2230363Certificate of AnalysisJul 15, 2022 L305002
A2220131Certificate of AnalysisDec 29, 2021 L305002
A2220465Certificate of AnalysisDec 29, 2021 L305002
A2220144Certificate of AnalysisDec 29, 2021 L305002

Show more⌵

Chemical and Physical Properties

SensitivityMoisture sensitive. heat sensitive

Related Documents

Reviews

Customer Reviews

Citations of This Product

1. Bing Yang, Xiaochun Wu, Jingqi Zeng, Jinjing Song, Tianhao Qi, Yanjun Yang, Dingkun Liu, Yulin Mo, Miao He, Liang Feng, Xiaobin Jia.  (2023)  A Multi-Component Nano-Co-Delivery System Utilizing Astragalus Polysaccharides as Carriers for Improving Biopharmaceutical Properties of Astragalus Flavonoids.  International Journal of Nanomedicine,      [PMID:38026532] [10.2147/IJN.S434196]
2. Xiaochen Chen, Yiwei Wang, Changzhu Li, Zichun Hua, Haiying Cui, Lin Lin.  (2023)  Antibacterial effect of protease-responsive cationic eugenol liposomes modified by gamma-polyglutamic acid against Staphylococcus aureus.  JOURNAL OF LIPOSOME RESEARCH,    (19):   [PMID:37966062] [10.1080/08982104.2023.2280829]
3. Pan Mingzhu, Liu Yali, Sang Tian, Xie Jiajun, Lin Huishu, Wei Jianpeng, Shao Shuai, Zheng Yanying, Zhang Juan.  (2023)  Enhanced antitumor and anti-metastasis by VEGFR2-targeted doxorubicin immunoliposome synergy with NK cell activation.  INVESTIGATIONAL NEW DRUGS,  41  (5): (664-676).  [PMID:37542666] [10.1007/s10637-023-01372-5]
4. Chu-tong Tian, Jing-jing Guo, Yi-fan Miao, He-lin Wang, Qing Ye, Chun-lin Guo, Ming-yang Zhang, Zhong-gui He, Jin Sun.  (2022)  Long chain triglyceride-lipid formulation promotes the oral absorption of the lipidic prodrugs through coincident intestinal behaviors.  EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS,  176  (122).  [PMID:35643367] [10.1016/j.ejpb.2022.05.015]
5. Peng Ji, Xianglong Wang, Jiabing Yin, Yansheng Yao, Wangqi Du.  (2022)  Amplification of ferroptosis with a liposomal nanoreactor cooperates with low-toxicity doxorubicin apoptosis for enhanced tumor chemotherapy.  Biomaterials Science,  10  (6): (1544-1553).  [PMID:35171184] [10.1039/D2BM00079B]

References

1. Bing Yang, Xiaochun Wu, Jingqi Zeng, Jinjing Song, Tianhao Qi, Yanjun Yang, Dingkun Liu, Yulin Mo, Miao He, Liang Feng, Xiaobin Jia.  (2023)  A Multi-Component Nano-Co-Delivery System Utilizing Astragalus Polysaccharides as Carriers for Improving Biopharmaceutical Properties of Astragalus Flavonoids.  International Journal of Nanomedicine,      [PMID:38026532] [10.2147/IJN.S434196]
2. Xiaochen Chen, Yiwei Wang, Changzhu Li, Zichun Hua, Haiying Cui, Lin Lin.  (2023)  Antibacterial effect of protease-responsive cationic eugenol liposomes modified by gamma-polyglutamic acid against Staphylococcus aureus.  JOURNAL OF LIPOSOME RESEARCH,    (19):   [PMID:37966062] [10.1080/08982104.2023.2280829]
3. Pan Mingzhu, Liu Yali, Sang Tian, Xie Jiajun, Lin Huishu, Wei Jianpeng, Shao Shuai, Zheng Yanying, Zhang Juan.  (2023)  Enhanced antitumor and anti-metastasis by VEGFR2-targeted doxorubicin immunoliposome synergy with NK cell activation.  INVESTIGATIONAL NEW DRUGS,  41  (5): (664-676).  [PMID:37542666] [10.1007/s10637-023-01372-5]
4. Chu-tong Tian, Jing-jing Guo, Yi-fan Miao, He-lin Wang, Qing Ye, Chun-lin Guo, Ming-yang Zhang, Zhong-gui He, Jin Sun.  (2022)  Long chain triglyceride-lipid formulation promotes the oral absorption of the lipidic prodrugs through coincident intestinal behaviors.  EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS,  176  (122).  [PMID:35643367] [10.1016/j.ejpb.2022.05.015]
5. Peng Ji, Xianglong Wang, Jiabing Yin, Yansheng Yao, Wangqi Du.  (2022)  Amplification of ferroptosis with a liposomal nanoreactor cooperates with low-toxicity doxorubicin apoptosis for enhanced tumor chemotherapy.  Biomaterials Science,  10  (6): (1544-1553).  [PMID:35171184] [10.1039/D2BM00079B]

Solution Calculators